JC

Jingtai Cao

RP Regeneron Pharmaceuticals: 13 patents #83 of 810Top 15%
📍 White Plains, NY: #150 of 917 inventorsTop 20%
🗺 New York: #11,369 of 115,490 inventorsTop 10%
Overall (All Time): #370,077 of 4,157,543Top 9%
13
Patents All Time

Issued Patents All Time

Showing 1–13 of 13 patents

Patent #TitleCo-InventorsDate
12082565 Non-human animals models of retinoschisis Susannah Brydges, Yajun Tang, Yang Liu, Carmelo Romano 2024-09-10
11178860 Humanized C5 animals Ying Hu, Adrianna Latuszek, Alexander O. Mujica, Stanley Wiegand, Andrew J. Murphy 2021-11-23
11104730 Methods of treating eye disorders with APLNR antagonists and VEGF inhibitors Eunice Cheung, Ivan B. Lobov 2021-08-31
11071780 Methods and formulations for treating vascular eye diseases using aflibercept and nesvacumab Robert L. Vitti, Kristine A. Erickson, Karen Chu, Stanley Wiegand, Ivan B. Lobov +3 more 2021-07-27
11064685 Non-human animal models of retinoschisis Susannah Brydges, Yajun Tang, Yang Liu, Carmelo Romano 2021-07-20
10524458 Humanized C3 animals Ying Hu, Adrianna Latuszek, Alexander O. Mujica, Stanley Wiegand, Andrew J. Murphy 2020-01-07
10492477 Humanized C5 animals Ying Hu, Adrianna Latuszek, Alexander O. Mujica, Stanley Wiegand, Andrew J. Murphy 2019-12-03
9795121 Humanized C3 animals Ying Hu, Adrianna Latuszek, Alexander O. Mujica, Stanley Wiegand, John McWhirter +2 more 2017-10-24
7531173 Ophthalmic composition of a VEGF antagonist Stanley Wiegand 2009-05-12
7378095 Methods of treating type I diabetes by blocking VEGF-mediated activity Li-Hsien Wang, Hsin-Chieh Lin, Mark Sleeman, Stanley Wiegand 2008-05-27
7303748 Method of treating eye injury with local administration of a VEGF inhibitor Stanley Wiegand 2007-12-04
7300653 Method of treating corneal transplant rejection Stanley Wiegand, Claus Cursiefen 2007-11-27
7300654 Method of treating corneal transplant rejection in high risk keratoplasty patients Stanley Wiegand, Claus Cursiefen 2007-11-27